Read More 1 minute read Analyst Ratings News Price Target SVB Leerink Maintains Outperform on AC Immune, Lowers Price Target to $10 By Benzinga Newsdesk July 11, 6:52 AM SVB Leerink analyst Marc Goodman maintains AC Immune (NASDAQ:ACIU) with a Outperform and lowers the price target from $15 to $10. ACIU
Read More 1 minute read Analyst Ratings News Price Target SVB Leerink Maintains Outperform on 89bio, Lowers Price Target to $29 By Benzinga Newsdesk July 11, 6:49 AM SVB Leerink analyst Thomas Smith maintains 89bio (NASDAQ:ETNB) with a Outperform and lowers the price target from $50 to $29. ETNB
Read More 1 minute read Analyst Ratings Initiation News Price Target Wells Fargo Initiates Coverage On G-III Apparel Group with Equal-Weight Rating, Announces Price Target of $20 By Benzinga Newsdesk July 11, 6:48 AM Wells Fargo analyst Ike Boruchow initiates coverage on G-III Apparel Group (NASDAQ:GIII) with a Equal-Weight rating and announces Price Target of $20. GIII
Read More 1 minute read Analyst Ratings News Price Target Piper Sandler Maintains Overweight on Blackstone, Lowers Price Target to $154 By Benzinga Newsdesk July 11, 6:46 AM Piper Sandler analyst Sumeet Mody maintains Blackstone (NYSE:BX) with a Overweight and lowers the price target from $169 to $154. BX
Read More 1 minute read Analyst Ratings News Price Target Stephens & Co. Maintains Overweight on Murphy USA, Raises Price Target to $300 By Benzinga Newsdesk July 11, 6:44 AM Stephens & Co. analyst Ben Bienvenu maintains Murphy USA (NYSE:MUSA) with a Overweight and raises the price target from $290 to $300. MUSA
Read More 1 minute read Biotech General Health Care Movers News Penny Stocks Trading Ideas Patient Death Prompts MacroGenics To Close Mid-Stage Head & Cancer Study By Vandana Singh July 11, 6:40 AM MacroGenics Inc (NASDAQ:MGNX) closed the Phase 2 study (CP-MGA271-06) of enoblituzumab in the first-line treatment of patients with recurrent or metastatic… MGNX
Read More 1 minute read Analyst Ratings News Price Target Mizuho Maintains Buy on DTE Energy, Lowers Price Target to $130 By Benzinga Newsdesk July 11, 6:39 AM Mizuho analyst Anthony Crowdell maintains DTE Energy (NYSE:DTE) with a Buy and lowers the price target from $137 to $130. DTE
Read More 1 minute read Tech STMicroelectronics And GlobalFoundries To Advance FD-SOI Ecosystem With New 300MM Manufacturing Facility In France By Bill Haddad July 11, 6:38 AM -Reuters GFS
Read More 1 minute read Analyst Ratings News Price Target Credit Suisse Maintains Outperform on Boston Beer Co, Lowers Price Target to $400 By Benzinga Newsdesk July 11, 6:35 AM Credit Suisse analyst Kaumil Gajrawala maintains Boston Beer Co (NYSE:SAM) with a Outperform and lowers the price target from $620 to $400. SAM
Read More 2 minute read News Tech Why Apple’s 5G iPhones, iPads Have Been Banned In Colombia By Shivdeep Dhaliwal July 11, 6:34 AM Apple Inc's (NASDAQ: AAPL) iPhones and iPads capable of communicating using 5G technology have been banned in Colombia. AAPL